Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RQHTF
HAMILTON, Ontario, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed a contract with a network of 15 Skilled Nursing Facilities (SNFs) in California. This contract is expected to add a further 1,000 new patients per month or 12,000 new patients per year to Reliq’s iUGO Care platform beginning in 2023.
“We are very pleased to be expanding into the Skilled Nursing Facility market in California,” said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. “Reliq will be providing our iUGO Care Transitional Care Management (TCM), Remote Patient Monitoring (RPM), Chronic Care Management (CCM) and Behavioural Health Integration (BHI) solutions to help improve post-discharge health outcomes and reduce readmissions, while also generating new revenue streams for the facilities. The Company will provide TCM to newly discharged patients at a rate of $60 per patient, with recurring revenue from RPM, CCM and BHI of $65/patient per month, at 75% gross margin. We will begin onboarding patients with these facilities in early 2023. Once all 15 facilities are live we expect to onboard over 1,000 of their newly discharged patients every month. The Skilled Nursing space is currently one of our fastest growing market segments and we are excited to help SNFs provide new healthcare services to their patients to drive better outcomes.”
Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN: A2AJTB.
$RQHTF Announced Contract for 12000 new patients per year though Skilled Nursing Facilities in California.
Reliq Health is a rapidly growing MedTech company that generates recurring revenues though subscriptions for the monitoring of chronic health conditions primarily in the US. Fully covered through Medicare and Medicaid as well as private insurance, the company does live monitoring of a host of condition reducing incidents of crisis and hospitalization significantly improving outcomes and reducing costs.
Reliq provides direct support to the patients and provides the software and monitoring to Doctors and medical practices. Doctors bill the insurer $400 a month for the monitoring. The doctors pay between $40-$100 to Reliq to provide the service. Everyone makes money and everyone improves the outcomes.
The company is at an inflection point where their sales will exceed their expenses and that transition will shift to significant profits very quickly. They have well over a million patients under contract and is putting them on the system at an exponential rate. 50k on by end of June 2022, 100k on by end of December 2022 and over 200k by end of June 2023. That will put their monthly revenues over 10M a month while still having accelerated growth through 2023 and beyond.
Excess cash is being put to share buy backs and uplisting to the NASDAQ one the share price meets the listing requirements without having to do a reverse split.
This is a stock I like to refer to as a retirement builder. Should generate a minimum 10x over the next 2 years. Do some DD. First Quarter financial is due in the next 2 weeks so you will not have to wait long for confirmation of the direction and information I have provided here. When this company gets noticed, the easy and big gains will be gone so start a position now.
Good Luck
$RQHTF Announced Contract for 12000 new patients per year though Skilled Nursing Facilities in California.
Reliq Health is a rapidly growing MedTech company that generates recurring revenues though subscriptions for the monitoring of chronic health conditions primarily in the US. Fully covered through Medicare and Medicaid as well as private insurance, the company does live monitoring of a host of condition reducing incidents of crisis and hospitalization significantly improving outcomes and reducing costs.
Reliq provides direct support to the patients and provides the software and monitoring to Doctors and medical practices. Doctors bill the insurer $400 a month for the monitoring. The doctors pay between $40-$100 to Reliq to provide the service. Everyone makes money and everyone improves the outcomes.
The company is at an inflection point where their sales will exceed their expenses and that transition will shift to significant profits very quickly. They have well over a million patients under contract and is putting them on the system at an exponential rate. 50k on by end of June 2022, 100k on by end of December 2022 and over 200k by end of June 2023. That will put their monthly revenues over 10M a month while still having accelerated growth through 2023 and beyond.
Excess cash is being put to share buy backs and uplisting to the NASDAQ one the share price meets the listing requirements without having to do a reverse split.
This is a stock I like to refer to as a retirement builder. Should generate a minimum 10x over the next 2 years. Do some DD. First Quarter financial is due in the next 2 weeks so you will not have to wait long for confirmation of the direction and information I have provided here. When this company gets noticed, the easy and big gains will be gone so start a position now.
Good Luck
The wait is finally over. $BKTPF finally had some news. Cruz Battery Metals Corp announced today that they have gotten approval for 22 more drill holes on the Solar Lithium Project in Nevada. This project is huge with a footprint over 8000 acres and it sits in a very prospective location bordering American Lithium. Company hit in every hole drilled to date and hit a high of 26.9 cents on the last work program. This has massive potential here with Lithium trading at all time highs. Great price for people to get in now for a trade. If you are here seeing this now add BKTPF to your watch list and holdings. Work and news will drive this.
$RQHTF is up over 25% this week. Company is ready to break out. Company has recently announced some massive contracts and will post financial report for July - September in a couple weeks. Company is expected to post good numbers and rally into the new year. This is worth some DD.
$RQHTF / $RHT announced a massive contract again. Adding 60K patients to the service annually starting in 2023. The contract today is similar to the contract announced on October 26th where they announce another huge contract of 50K patients to be added to the service in 2023. At the same time they are adding similar numbers from DataSoft Logic annually. They currently have booked commitments for service over 200k patients in 2023 and over 1M patients on contract to be added as clinics and providers are ready.
The growth potential is huge. Their Year end report showed 485% growth Y/Y and they have 2023 income expected to be exponentially more than that. Their business model is primarily SaaS where they earn $40-$80per patient on the service on a monthly subscription basis. They are paid by doctors who get paid by Medicare, medicaid and private insurance to track and monitor people with chronic health conditions in their homes dramatically decreasing the overall medical costs by preventing hospitalization and incidents. Profit margins projected at 75% gross sales.
There are not a lot of clear 10 bagger stocks out there but this is one you need to put on your list. Long holds can expect the company to be bought out within 2 years. Expected and announced for 2023, excess cashflow will be used for share buybacks and they will up list to the nasdaq. Based on their sales trajectory, they will be over 1B market cap by the end of 2023 with a modest PE ratio.
$RQHTF / $RHT announced a massive contract again. Adding 60K patients to the service annually starting in 2023. The contract today is similar to the contract announced on October 26th where they announce another huge contract of 50K patients to be added to the service in 2023. At the same time they are adding similar numbers from DataSoft Logic annually. They currently have booked commitments for service over 200k patients in 2023 and over 1M patients on contract to be added as clinics and providers are ready.
The growth potential is huge. Their Year end report showed 485% growth Y/Y and they have 2023 income expected to be exponentially more than that. Their business model is primarily SaaS where they earn $40-$80per patient on the service on a monthly subscription basis. They are paid by doctors who get paid by Medicare, medicaid and private insurance to track and monitor people with chronic health conditions in their homes dramatically decreasing the overall medical costs by preventing hospitalization and incidents. Profit margins projected at 75% gross sales.
There are not a lot of clear 10 bagger stocks out there but this is one you need to put on your list. Long holds can expect the company to be bought out within 2 years. Expected and announced for 2023, excess cashflow will be used for share buybacks and they will up list to the nasdaq. Based on their sales trajectory, they will be over 1B market cap by the end of 2023 with a modest PE ratio.
$RQHTF Released their Audited Year End Financials this morning and the info showed significant progress towards becoming a 1B market cap company in the near future. Being a Canadian Company their year end is at the end of June. This means they will report their 1st Quarter results at the end of November (60 days after for quarterly and 120 Days for Year end.) Due to this timing there is going to be a major catalyst in less than a month. The company is projected to double their sales between July 1st and January 1st so this upcoming report should show a significant increase in revenues again.
Highlights from FY 2022 Annual Audited Financial Statements.
Increased sales 485% to $8,551,807 for FY 2022 relative to $1,462,165 for FY 2021.
Increased revenue from software and services by over 1,940% to $2,739,516 for FY 2022 (FY 2021 - $134,264). Going forward the Company expects the majority of its revenue in 2023 and beyond to come from higher margin software and services vs device sales.
Increased gross profits over 515% to $5,301,304 for FY 2022 (FY 2021 - $857,954). Gross Margin for the year was 62%. The gross margin was affected by a temporary increase in device costs in Q3 and Q4 FY 2022 which has subsequently been resolved as the Company identified new device suppliers. Gross margins are expected to reach the target 75% in 2023 due to reduced device costs and an increase in the percentage of the Company’s total revenues from higher margin software and services vs device sales.
On January 1, 2022 CMS introduced five new billing codes for Remote Therapeutic Monitoring (RTM), allowing clinicians to provide ongoing in-home treatment and monitoring for patients with musculoskeletal and respiratory conditions. RTM involves having patients use medical devices that collect non-physiological data such as therapy/medication adherence and therapy/medication response, and also allows for patient self-reporting of key metrics such as pain level, mobility, nighttime waking due to breathing difficulties, etc. The new RTM codes have increased Reliq’s target patient population by over 20 million newly eligible patients to over 57 Million total eligible patients in the US alone.
Signed an agreement with Data Soft Logic (DSL) to provide iUGO Care to DSL’s existing and new clients. Data Soft Logic currently has over 600 home health and hospice care agency clients who work with more than 1,000 primary care physicians to provide care to over 500,000 Medicare and Medicaid patients. Reliq started onboarding DSL’s patients in Q2 Calendar Year 2022 and expects to ramp up to adding over 50,000 new patients per year each year beginning in 2023, at an estimated revenue of $60 per patient per month.
Signed an agreement with Cognizant to leverage Cognizant’s Care Management resources for future deployments of Reliq’s iUGO Care software to large scale clients. Cognizant provides services to 300+ health systems and over 347,000 care providers who together provide care to over 200 million lives globally. The agreement with Cognizant will allow Reliq to scale to new levels and provide even the largest healthcare organizations with confidence that the Company can meet the needs of their patient populations, no matter the size, allowing Reliq to access new opportunities to provide virtual care to much larger patient populations both within the US and globally.
Signed a contract with a large physician practice network in Florida to onboard over 50,000 patients to its iUGO Care platform by the end of 2023.
Signed a contract with a network of 40 Skilled Nursing Facilities (SNFs) in Florida which is expected to add over 48,000 patients to its iUGO Care platform every year beginning in 2023.
Signed contracts with 99 new US primary care physician practices and 28 other healthcare organizations in specialties including hospice care, nephrology, orthopedics, long term care, skilled nursing, hospital care, cardiology and care management.
Signed contracts with 25 new home health agencies in the US and 3 adult medical day care facilities.
Signed an agreement with a US Contract Research Organization to use Reliq’s iUGO Care software and Patient Engagement services to support their oncology and other clinical trials.
If this is the first you are seeing on Reliq Health you want to look at this now. This has the potential to be a 10 bagger or more in the next 12 months and realistically will be bought out by a larger company in a year or two.
$RQHTF Reports Reveune up 485% Year over Year.
Increased sales 485% to $8,551,807 for FY 2022 relative to $1,462,165 for FY 2021.
Increased revenue from software and services by over 1,940% to $2,739,516 for FY 2022 (FY 2021 - $134,264). Going forward the Company expects the majority of its revenue in 2023 and beyond to come from higher margin software and services vs device sales.
About 3M share short at the moment. First Quarter financial report out at the end of November. Will show significant growth again. This one could see a lot of short covering between now and that report.
Currently doubling sales every 6 months and forecast to continue for the next 12 months. Over 1M clients in the pipeline.
Business model is subscription based health monitoring largely paid for my Medicare and Medicaid. Doctors charge for the service and get paid about 400 a month to use the system. Doctors pay Reliq $60 to provide the service. At that price the subscriptions are roughly 75% gross profit. This service is beneficial to everyone. Patients get better care, Doctors are able to bill for service, Relic makes a good margin.
When people find this one it will take off.
$RQHTF Announces huge new Contracts for 40k patients. Financial reports out Friday and at the end of November. Company's Growth is exponential going forward with paying clients doubling every 6 months now. Easiest 10x you will find. Not a day trade but easy money. Do your DD. Last 4 quarters have shown significant growth and the company will be showing profitability by the November First Quarter release.
$RQHTF Reliq Health Technologies Insider buying Yesterday.
CEO- Lisa Crossley picked up over 101k shares yesterday for her second large stock purchase at market in the last 2 months. Two financial reports expected in the next 10 weeks so now it is the time to do some serious dd on this one.
RQHTF CEO buying shares at market. 101k yesterday. Big things coming, Recently signed second largest contract in company history. Has 2 financial reports out in the next 65 days. You want to look at Reliq Health Technologies now.
$RQHTF is a hidden gem. Reliq Health Technologies announced today they have secured a new contract for 50k new patients to be added to their service over the next 15 months.
Reliq is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.
Company has posted significant quarterly growth over the last 4 quarters and is now at an inflection point where their SaaS contract revenues will blow past their monthly operating expenses and the company will show both profitability and rapid growth going forward. All contracts are month subscriptions so new numbers build upon previous numbers with very little attrition. Current projections have the company expecting to have 100k patients on the service by end of 2022 and 200k on the service by end of June 2023. The company nets an average of $50 per person on the subscription so gross revenues at end of the year is roughly 5M a month with mid 2023 expected to be 10M a month. With revenues like that it will not remain a penny stock for long. Company has announced plans to uplist on to the NASDAQ as well as put profits towards share buy backs to drive investor value.
Current short position is about 4M shares currently and the CEO just bought 49,000 shares in the market in the last 2 weeks. Always a good sign when insiders are buying.
Do some research on this one. It has lots of upside and very little downside risk. The company will release their year end financial report at the end of October and the first quarter report at the end of November (It is a Canadian company so the financial dates reflect the Canadian Exchanges rules). This won't stay under the radar for long and when it starts getting traction it will go fast as the shorts have to cover.
In TA it could dip a little but long term it is on the launch pad. Good Luck.
$RQHTF Reliq Health Technologies announced contract for 50k new patients today. The company is right now at an inflection point where it will shift from Cash burn to profitability and should make significant gains over the next 6 months. Company boast a massive stockpile of contracts to grow their business over the next several years, a profit margin of 75% on monthly recurring revenues and will post year end financial and first quarter financial within the next 3 months. (End of October and End of November). Companies performance has shown significant improvement over the last 4 quarters and the forward projections are very solid.
Revenue projections have the company on pace for 5M a month in revenues by End of 2022 and 10M a month by end of June 2023. This rapid growth will ensure the company will be a target for acquisition which will only benefit shareholders.
Company plans include, eventual up-listing to the NASDAQ and share buybacks with profits in the short term.
This company is relatively un-followed at this time and will definitely be making some substantial moves in the near future. Trading well below the highs. Honestly the best play I know trading below a buck. Don't take my word for it though. Do some DD. I expect it will be at least 10x over the next 12 months and the down side is very low. If you have a better play with less risk let me know.
$RQHTF again had huge news today. Company signed what is their second largest contract in company history second only to Data Soft Logic. Today's news will add 50000 patients to the service at an average of $60 per patient with a margin of 75%. Reliq has confirmed in past news releases that they expect to have over 100k people on the service at end of 2022 and 150k on by end of June 2023. Adding this 50k will put them well over 200k patients before the end of next year. At a modest average of $50 a patient that will equal $10M a month in revenues.
This company's valuation is going to explode over the next year and a half. I would be shocked if it didn't get bought out before 2024...
RQHTF Reliq Health Technologies adds contracts, Short position increased to around 4 million shares. They are going to have to cover as the company is on track to have 5 million a month in revenue by the end of 2022 and 10 million a month by mid 2023. Do some DD on this one. It is an easy multi-bagger Will double by November and should be 5-10x by next year.
$RQHTF - Reliq Health Technologies is now just a couple months from posting their break out financial report. Today they announced eight new clinics and up to 5000 additional patients for the service. They also announced being on track to hit 100k patents on they system by the end of 2022 and over 200k patients on by the middle of calendar year 2023. This means by mid 2023 they will be making roughly 10M a month in recurring revenues with a gross margin of 75%.
This is on a fast track to 1B market cap. At current market prices this stock is a gift. This is 100% a multi-bagger as long as you have realistic timelines. Next financial report is at the end of October when it will break out. Next one is end of November which will solidify their rapid growth.
Current short position is 3.95M shares. These are going to have to cover very soon or they are going to get trapped so it looks like it is going to go fast when it moves.
Good luck and do some DD. ( I personally have 100k shares)
$CYDVF Announces 99.5% LCE Extraction from DLE at pilot plant. Cypress development is moving quickly towards mining the lithium clay deposit in Clayton Valley Nevada as the keep exceeding expectations on their Pilot plant. Cypress shares the deposit with $SPMTF which just announced they have more than doubled their deposit size to over 2 million tonnes of LCE. With the progress made and Lithium prices in general these two companies are at a decent discount right now. Do some DD and check them out.
$SPMTF is about 2 weeks away from an updated resource calculation which is being done by Stantec. If you are familiar with the company then you know Stantec provided a maiden resource calculation for the McGee lithium project last year and indicated 1,006,000 tonnes of LCE on the project. What stood out if you read the report is that the company was only given lithium values for land to the east of what was though of as a limiting fault that runs through the middle of the project. Since the report Spearmint has drilled the west side of the project and reported some of the best intercepts in Nevada history for lithium projects. 700 fee of economical grade lithium bearing clay-stones. It is due to these fantastic and surprising results I am expected a significant increase in the deposit size. With the current price it well should be worth a look.
Bordering the project to the North is Cypress Development Corp. who are currently running tests through their pilot plant proving the refinement of the deposit. As they prove the technology, the same processes can be used to extract the McGee project as it is shared with Cypress.
Spearmint is an exploration phase company and will look to maximize the resource size and then look to sell the project to a developer. As the demand starts to spiral I expect we could see this happen sooner than later. 2023 or 2024 would not be unexpected.
Do some DD and see if you see the value I do. I am a shareholder, not an advisor. GL
$BKTPF announced discovering lithium in all drill holes on the phase 2 drill program on the Solar lithium project. The project is over 8k acres in size and the company reported lithium on the north end and south end of the project. Expected later this year they will do a larger drill program to infill the property and delineate how much of the property is at economical grades. With the closest project to them being American Lithium's TLC project which boasts well over 5M tonnes of LCE this could be massive going forward. Cruz sports a low MC and low Float currently so it may be work looking into.
The world is moving into a major lithium shortage with the conversion of cars going EV. It has been reported that the industry is going to need $40B worth of investment over the next 10 years to meet demand. Lithium is the new oil. Whether you get Cruz or another lithium company you want to have exposure to the commodity and industry.
Do your DD, I am a shareholder, not an advisor. GL
$RQHTF is now 10 days away from posting their 3Q financials (Canadian Company). This report should show some good growth from the last set. In these financials should be so delayed AR and revenues from new onboarding. I am expecting record revenues. They well may not be the breakthrough, full profitability ones we are waiting for but ever quarter of reasonable growth is getting us closer to that mark. Sales are subscription based SaaS mostly funded by Medicare and Medicaid so if you haven't done your DD on this one, you need to do it. At current prices this should be an easy 10x over 24 months if not more.
Today they announced new contracts including clinical trials of more than 1000 patients. This adds another facet the company can tap to maximize growth and shareholder value as they grow in the future.
Company has a significant short holding due to a demonstrably false short report put out by White Diamond Research. It did cause the company to shed about 1/3 of its value but if this is new to you that means you can get in now at a steep discount to most of the people who bought in over the last 12 months.
I am not an advisor, do your DD. I have personal shares. I am not associated with the company in any way. GL.
$RQHTF had good news again today. New Contracts in Texas and California as well as a health network in Nevada that adds up to 8000 new patients to be added to the system by the end of the year. These contracts are expected to average over $60 per patient so when fully realized this will add $480000 in monthly revenues or over $5.5M a year on top of the other agreements they are adding to the service monthly.
This is showing rapid growth YoY and a real potential to be a 10x win for those who are in long term. Currently Reliq is the second most shorted stock on the TSXV and with a little buying those shorts will have to cover. Next financial report in just over 1 month will be a significant catalyst for the company. Record revenues are expected to further the growth story.
I am not an advisor but do have shares. Do your DD. GL.
https://ca.finance.yahoo.com/news/reliq-health-technologies-inc-announces-070100175.html
$RQHTF is going to get a nice bump over the next few days. The company has addressed the demonstrably false report by White Diamond Research. Price already recover from the short term dip. With over 5M shares currently short that have to cover there should be a lot of buying over the next little bit while they try to get out of trouble. Good time to screw over shorties... GL. Do your DD. I am not an advisor...
$RQHTF Short Squeeze in play now!!!
White Diamond Research put out a demonstrably false hit piece on Reliq on Thursday. Company has responded informally at first and formally yesterday and today. Stock is over 5M shares short and the price is already back to where it was. Has not traded enough to cover the shorts so they are going to have to buy back higher. Shorters are going to get beaten on this one. Looks like a fast 20% or more for a few days trade. Punish the shorts and make some money... WIN WIN..
Do your own DD, I am not an advisor.
$CSRNF is 26% Sprott owned. Drill Results expected soon. Massive potential on this Newfoundland Gold play. Low float, Low MC, 6 Million Dollar Drill program. This has a lot of upside right now. Assume 6-8 week hold but you probably won't get in much cheaper at this point. Canadian Symbol is $ROX.v. Canstar Resources. Do some DD.
Sprott did buy into $SPMTF for a few projects. Perron and Goose. Perron has been drilled and Goose is to come. Their Flagship which has over 1 million tonnes of LCE has their updated calculations coming and probably will double the estimate to 2M tonnes of LCE giving them roughly 40% of the LCE that the neighboring Cypress project has. Just on the McGee project alone this should be trading much higher than it is now. When it has the updated calculation it should double minimum if not triple. They are currently trading around 7% of Cypress and on deposit alone they should be 20%. Now toss in Lithium prices and they should valued better than last year when the initial estimates were done which was double what they are today. Glad to be holding this one.
$SPMTF Spearmint Resources updated Lithium Deposit Estimate Soon.
Spearmint Resources shares a deposit with Cypress Development and is expecting an updated resource estimate shortly. Currently sitting on 1,006,000 Tonnes of LCE, this calculation is expected to Double the size of the deposit from 20% of Cypress to 40% of Cypress. Same Deposit. Currently trading 7% of Cypress it is way undervalued based on the location and deposit size. Recently Cypress proved viability of Lithium Extraction from the deposit through their pilot plant and is now actively looking for Joint Ventures. Toss in Lithium being up Over 900% since January 2021 and Spearmint should be a good play with the news coming soon. On the initial resource estimate the share price was double where it is today so I figure this has 2x-4x potential over the next 30 days.
Do some DD. You want lithium in your portfolio and SPMTF is very undervalued at this time. Should be an easy trade.
You are not wrong. All of the Lithium stocks including the Miners are disconnected from the sky rocketing value of the commodity. If they start to catch up they will all go way past anything I can imagine. Hard to pick a bad one in this market. Especially since the lithium value is not tied to instability. We are going to need as much as we can produce if we are going to move forward greener. (At least until we have a better portable power storage option...)
I could be wrong but I think this is just the beginning. The land size that they have could actually pan out to be the Biggest Deposit in Nevada although we clearly have a lot of work to see before they can start making those claims. I would be surprised with we don't see $0.40 to $0.50 by the time the drill program finishes. We have a few weeks to get there. Probably won't finish drilling until end of April but then we should see some nice action. Hard not to be excited. $BKTPF
Cruz $BKTPF announced that they hit 700 feet of the targeted lithium clay on the first hole of the phase 2 lithium drill program. It doubled the length of the first phase drill holes and looks to be the biggest intercept for this type of program in Nevada history. This has a lot of upside potential now. Should be drilling for 2 more weeks or so. The results likely in about 6 weeks.
$BKTPF provides drilling update. Hit 700 feet of the targeted lithium bearing clay on the first hole on the Phase 2 drilling program on the Solar Lithium project in Smoky Valley, Nevada. For scale, this is the biggest intercept seen in Nevada on these types of projects. Next closest I can find is on SPMTF with 650 feet on the McGee Claims. LIACF which borders the Solar project only reported depths to a maximum of 400 feet and intercepts under 360 feet. This is very early in the project and what will matter is the rest of the holes but this looks like a lot of potential here. Low float, Small market cap and significant size of the project at over 8000 acres. They keep having success and this could be a buck when they are done and have the results from this drill program. Cruz Battery Metals is also traded on the CSE under CRUZ.
I am not an advisor but am a shareholder. Do your DD.
$BKTPF Cruz Battery Metals Breakingout on Drill program.
Well off recent highs. Technicals showing a buy rating. Phase one drill program was cut short but had good results. Phase 2 program will complete the initial program and should signal the value of this large lithium clay project that borders American Lithium's TLC project. Float is only 99m shares, market Cap is under 16M so lots of potential. Neighbouring project has Market Cap over 600M. Very speculative with lots of potential.
$BKTPF Cruz Battery Metals Starts Solar Drill Program 0.16
This project borders American Lithium who is over 600m market cap. Cruz is tiny with 16m market cap. First 2.5 holes were very good on the last drill program so with success on this program it could be a nice run. Trading well below the highs it is a good time to look at this one for a trade. GL
$BKTPF Announced today that they are drilling on the SOLAR lithium project again. With only 5% of the project previously drilled this is excellent news as the project is huge and with it bordering LIACF it has potential to be one of the biggest deposits for Lithium Clay in Nevada. Cruz sitting at 16M market cap when American Lithium is 600m tells me that there is huge potential for a multi-bagger on this one now.
#BKTPF posted good results from the limited phase 1 drill program and has said they are going to return to the Solar Lithium Project this month. Expected to start drilling in within 2 weeks. With their low float, massive project size and the initial hole results anyone holding should be in for a good run once the drilling starts. Market cap for BKTPF is 15M, Neighbouring project LIACF is around 500M. Feels like a lot of upside. This one could easily get to $1 a share on drilling and more positive results. Now is the time to buy, stable and before the work starts. Good Luck everyone.
$BKTPF announced drilling results on Solar Lithium Project.
Multiple intercepts of the targeted potential lithium-bearing claystone formation were encountered in all the holes drilled in this initial phase of drilling. Values in Hole 1 were as high as 1,300 ppm/Li and encountered lithium bearing clays from 10 feet to 200 feet with a 60-foot intercept averaging 968.33 ppm/Li. Hole 2 had a high value of 1120 ppm/Li including a 60-foot interval averaging 768 ppm/Li.
$SPMTF Spearmint Resources has started drilling Lithium in Clayton Valley Nevada. Last drill program took the stock from .05 to .32, Currently trading 0.125 it should take a decent run over the next few weeks on the news flow. If you are not greedy you should be able to trade it for a nice win.
$RQHTF agreement with Congizant is Huge.
Congizant is 185 on the Fortune 500 list and boasts and impressive list of assets that bodes extremely well for Reliq Health as they move forward into their rapid growth phase. Cognizant provides Reliq a path to provide their IUGO health monitoring service to large scale providers without impacting their current operations of uploading 5000 patients on to the service monthly. One of the big challenges with adding patient is hiring care managers to facilitate the integration and to work with the clients and patients and currently it has been the limiting factor keeping the company fixed to the growth projections they have publicly released including having 100k subscribers on the service by end of 2022. Cognizant changes all of this... Realize, Cognizant does not make this deal without months and months of internal due diligence. If Cognizant believes... well... you know the rest.
Cognizant has the immediate ability to provide management, web services and uploading services and at a cost cheaper than Reliq can currently provide. Cognizant can, without up front cost, put 30k -100k people on the system in a month utilizing existing staff and infrastructure within their existing systems. At a cost cheaper than Reliq providing room to net profitability without impacting the bottom line of Reliq. In addition to an assumed finders fee for clients brought in through their vast pool of clients and patients this is an easy win win for both companies. Cognizant currently provides services to 300+ health systems, 347000+ care providers and 200m people globally. This is good for them both.
Reliq provides chronic health monitoring to patients primarily in the US through Medicare and Medicaid funding. A patient that need home monitoring will be put on the service by they doctors at no cost to the patient. The average clinical practice can generate new revenue of over $372 USD per patient per month in payments from CMS by deploying iUGO Care. Hospital admissions are reduced by over 90% in chronic disease patients using iUGO Care, and the average cost to the healthcare system is reduced by over 80%. In addition current gross margins are over 75% and are expected to increase. EBITDA margins are greater than 45%.
Currently the company has 40k clients on the subscription service and over 500,000 in queue to go on the system. At their very manageable pace of adding 5,000 people to the system a month, by the end of 2022 they will have 100k people on the service with a monthly revenue of $5 million. This is without any additional assistance from their agreement with Cognizant. The company has mentioned they have been working on some huge contracts with millions of patients of which there would be some significant uploads of patients as part of the agreements and for those who haven't been paying attention, this is what Cognizant brings to the table. The ability to immediately and effectively deliver on these contracts.
If you have gotten this far, I hope you will take some time to do an objective deep dive into this company and the potential for the investment. I expect them to absolutely crush their projections now that they have this agreement in place and now that I have an understanding of the arrangement I am even more convinced that this will be a massive win as a long term investment. With the key milestones expected this year including uplisting to NASDAQ in the second half of 2022 I strongly believe this could be 10x for those who buy and hold for a buy out or an easy 5x for those who just hold for the uplisting.
Good luck and do you DD. This is my biggest personal holding with a little over 100k shares.
$RQHTF agreement with Congizant is Huge.
Congizant is 185 on the Fortune 500 list and boasts and impressive list of assets that bodes extremely well for Reliq Health as they move forward into their rapid growth phase. Cognizant provides Reliq a path to provide their IUGO health monitoring service to large scale providers without impacting their current operations of uploading 5000 patients on to the service monthly. One of the big challenges with adding patient is hiring care managers to facilitate the integration and to work with the clients and patients and currently it has been the limiting factor keeping the company fixed to the growth projections they have publicly released including having 100k subscribers on the service by end of 2022. Cognizant changes all of this... Realize, Cognizant does not make this deal without months and months of internal due diligence. If Cognizant believes... well... you know the rest.
Cognizant has the immediate ability to provide management, web services and uploading services and at a cost cheaper than Reliq can currently provide. Cognizant can, without up front cost, put 30k -100k people on the system in a month utilizing existing staff and infrastructure within their existing systems. At a cost cheaper than Reliq providing room to net profitability without impacting the bottom line of Reliq. In addition to an assumed finders fee for clients brought in through their vast pool of clients and patients this is an easy win win for both companies. Cognizant currently provides services to 300+ health systems, 347000+ care providers and 200m people globally. This is good for them both.
Reliq provides chronic health monitoring to patients primarily in the US through Medicare and Medicaid funding. A patient that need home monitoring will be put on the service by they doctors at no cost to the patient. The average clinical practice can generate new revenue of over $372 USD per patient per month in payments from CMS by deploying iUGO Care. Hospital admissions are reduced by over 90% in chronic disease patients using iUGO Care, and the average cost to the healthcare system is reduced by over 80%. In addition current gross margins are over 75% and are expected to increase. EBITDA margins are greater than 45%.
Currently the company has 40k clients on the subscription service and over 500,000 in queue to go on the system. At their very manageable pace of adding 5,000 people to the system a month, by the end of 2022 they will have 100k people on the service with a monthly revenue of $5 million. This is without any additional assistance from their agreement with Cognizant. The company has mentioned they have been working on some huge contracts with millions of patients of which there would be some significant uploads of patients as part of the agreements and for those who haven't been paying attention, this is what Cognizant brings to the table. The ability to immediately and effectively deliver on these contracts.
If you have gotten this far, I hope you will take some time to do an objective deep dive into this company and the potential for the investment. I expect them to absolutely crush their projections now that they have this agreement in place and now that I have an understanding of the arrangement I am even more convinced that this will be a massive win as a long term investment. With the key milestones expected this year including uplisting to NASDAQ in the second half of 2022 I strongly believe this could be 10x for those who buy and hold for a buy out or an easy 5x for those who just hold for the uplisting.
Good luck and do you DD. This is my biggest personal holding with a little over 100k shares.
$SPMTF drilling in Quebec and will start drilling any day now on the McGee project in Clayton Valley. This one should take off soon. Can't imagine it will get cheaper with everything they are currently working on.